Pluri Inc. (PLUR) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)
Pluri Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Pluri Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($13.0M and $12.8M). Quoin Pharmaceuticals, Ltd. Sponsored ADR has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 13 metrics below, Quoin Pharmaceuticals, Ltd. Sponsored ADR leads on 7 and Pluri Inc. on 6.
Valuation
Profitability
| Metric | PLUR | QNRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 44.59% | 0.00% | 65.16% |
| Operating margin | (2,454.53%) | 0.00% | 0.00% |
| Net margin | (2,344.59%) | 0.00% | 0.00% |
| Free cash flow margin | (1,988.48%) | 0.00% | 0.00% |
| Return on equity | 260.35% | (575.73%) | (57.72%) |
| Return on assets | (74.95%) | (178.77%) | (49.22%) |
| Return on invested capital | (526.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack